Standout Papers

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2... 1998 2026 2007 2016 834
  1. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. (1998)
    Mark D. Pegram, A. Lipton et al. Journal of Clinical Oncology
  2. microRNAs exhibit high frequency genomic alterations in human cancer (2006)
    Lin Zhang, Jia Huang et al. Proceedings of the National Academy of Sciences
  3. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group (2004)
    Timothy R. Rebbeck, Tara M. Friebel et al. Journal of Clinical Oncology

Immediate Impact

10 by Nobel laureates 15 from Science/Nature 79 standout
Sub-graph 1 of 17

Citing Papers

Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA -Related Cancer
2019 Standout
56 intermediate papers

Works of Barbara Weber being referenced

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study
2006
Breast and Ovarian Cancer
2003
and 18 more

Author Peers

Author Last Decade Papers Cites
Barbara Weber 1042 843 4124 3261 2700 165 9.8k
Douglas T. Ross 103 278 2248 11131 7004 87 20.4k
Chun Li 145 68 1765 4706 1491 442 12.1k
Igor Jurišica 49 162 708 9773 4375 268 15.1k
Miguel Martín 124 43 1391 3742 5759 512 18.0k
Göran Roos 350 46 583 5194 1600 324 15.1k
Dianne M. Finkelstein 32 34 2082 3242 2395 206 17.2k
John M. Bennett 93 53 2281 11357 1674 386 40.2k
Kurt Zatloukal 21 60 1858 6935 2081 272 15.6k
Gary J. Miller 152 27 966 2568 1123 226 12.2k
Martin Dugas 39 142 710 4438 1035 336 9.5k

All Works

Loading papers...

Rankless by CCL
2026